The Italian Medicines Agency has made its decisions regarding the use of drug therapies to fight the virus public. The decisions include approvals of various experimental studies, including on the now famous drug Avigan; other decisions of general interest for the continuation of treatments and therapeutic plans during this difficult time have also been made public.

Our Healthcare and Life Sciences Focus Team, in collaboration with the Covid-19 Task Force, has prepared a summary of the strategy pursued by the Italian Medicines Agency. If you would like a copy, just email covid19@belex.com.